Login
Evidence Feed
About
Conferences
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
CANCER:
Glioma
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Related cancers:
‹
CNS Tumor (577
)
Brain Cancer (569
)
Neuroblastoma (54
)
Pituitary Gland Carcinoma (10
)
Meningioma (8
)
CNS Tumor (577
)
Brain Cancer (569
)
Neuroblastoma (54
)
Pituitary Gland Carcinoma (10
)
Meningioma (8
)
›
Associations
(526)
News
Trials
VERI cancer hierarchy
Reset Filters
MGMT promoter methylation
Glioma
MGMT promoter methylation
Glioma
temozolomide + AZD9574
Sensitive: D – Preclinical
Clin Cancer Res - 2 weeks (New D)
temozolomide + AZD9574
Sensitive
:
D
Clin Cancer Res - 2wk
temozolomide + AZD9574
Sensitive: D – Preclinical
Clin Cancer Res - 2 weeks
temozolomide + AZD9574
Sensitive
:
D
Clin Cancer Res - 2 weeks - (New D)
No biomarker
Glioblastoma
No biomarker
Glioblastoma
RZ-001
Sensitive: B - Late Trials
PRNewswire - 3 weeks (New B)
RZ-001
Sensitive
:
B
PRNewswire - 3wk
RZ-001
Sensitive: B - Late Trials
PRNewswire - 3 weeks
RZ-001
Sensitive
:
B
PRNewswire - 3 weeks - (New B)
No biomarker
Glioma
No biomarker
Glioma
DAY101
Sensitive: B - Late Trials
Day One Biopharmaceuticals Press Release - 4 weeks (New B)
DAY101
Sensitive
:
B
Day One Biopharmaceuticals Press Release - 4wk
DAY101
Sensitive: B - Late Trials
Day One Biopharmaceuticals Press Release - 4 weeks
DAY101
Sensitive
:
B
Day One Biopharmaceuticals Press Release - 4 weeks - (New B)
No biomarker
Glioblastoma
No biomarker
Glioblastoma
Byvasda (bevacizumab biosimilar)
Sensitive: A1 - Approval
Byvasda (bevacizumab biosimilar)
Sensitive
:
A1
Byvasda (bevacizumab biosimilar)
Sensitive: A1 - Approval
Byvasda (bevacizumab biosimilar)
Sensitive
:
A1
No biomarker
Astrocytoma
No biomarker
Astrocytoma
everolimus
Sensitive: A1 - Approval
everolimus
Sensitive
:
A1
everolimus
Sensitive: A1 - Approval
everolimus
Sensitive
:
A1
No biomarker
Astrocytoma
No biomarker
Astrocytoma
carmustine
Sensitive: A1 - Approval
carmustine
Sensitive
:
A1
carmustine
Sensitive: A1 - Approval
carmustine
Sensitive
:
A1
No biomarker
Ependymoma
No biomarker
Ependymoma
carmustine
Sensitive: A1 - Approval
carmustine
Sensitive
:
A1
carmustine
Sensitive: A1 - Approval
carmustine
Sensitive
:
A1
No biomarker
Anaplastic Astrocytoma
No biomarker
Anaplastic Astrocytoma
temozolomide
Sensitive: A1 - Approval
temozolomide
Sensitive
:
A1
temozolomide
Sensitive: A1 - Approval
temozolomide
Sensitive
:
A1
No biomarker
Glioblastoma
No biomarker
Glioblastoma
bevacizumab
Sensitive: A1 - Approval
bevacizumab
Sensitive
:
A1
bevacizumab
Sensitive: A1 - Approval
bevacizumab
Sensitive
:
A1
No biomarker
Glioma
No biomarker
Glioma
carmustine
Sensitive: A1 - Approval
carmustine
Sensitive
:
A1
carmustine
Sensitive: A1 - Approval
carmustine
Sensitive
:
A1
No biomarker
Glioblastoma
No biomarker
Glioblastoma
temozolomide
Sensitive: A1 - Approval
temozolomide
Sensitive
:
A1
temozolomide
Sensitive: A1 - Approval
temozolomide
Sensitive
:
A1
No biomarker
Glioblastoma
No biomarker
Glioblastoma
carmustine
Sensitive: A1 - Approval
carmustine
Sensitive
:
A1
carmustine
Sensitive: A1 - Approval
carmustine
Sensitive
:
A1
No biomarker
Glioblastoma
No biomarker
Glioblastoma
bevacizumab-bvzr
Sensitive: A1 - Approval
bevacizumab-bvzr
Sensitive
:
A1
bevacizumab-bvzr
Sensitive: A1 - Approval
bevacizumab-bvzr
Sensitive
:
A1
No biomarker
Glioblastoma
No biomarker
Glioblastoma
bevacizumab-awwb
Sensitive: A1 - Approval
bevacizumab-awwb
Sensitive
:
A1
bevacizumab-awwb
Sensitive: A1 - Approval
bevacizumab-awwb
Sensitive
:
A1
No biomarker
Glioblastoma
No biomarker
Glioblastoma
Krabeva (bevacizumab biosimilar)
Sensitive: A1 - Approval
Krabeva (bevacizumab biosimilar)
Sensitive
:
A1
Krabeva (bevacizumab biosimilar)
Sensitive: A1 - Approval
Krabeva (bevacizumab biosimilar)
Sensitive
:
A1
No biomarker
Glioma
No biomarker
Glioma
teserpaturev
Sensitive: A1 - Approval
teserpaturev
Sensitive
:
A1
teserpaturev
Sensitive: A1 - Approval
teserpaturev
Sensitive
:
A1
BRAF V600E
Glioma
BRAF V600E
Glioma
trametinib + dabrafenib
Sensitive: A1 - Approval
trametinib + dabrafenib
Sensitive
:
A1
trametinib + dabrafenib
Sensitive: A1 - Approval
trametinib + dabrafenib
Sensitive
:
A1
No biomarker
Glioblastoma
No biomarker
Glioblastoma
bevacizumab-maly
Sensitive: A1 - Approval
bevacizumab-maly
Sensitive
:
A1
bevacizumab-maly
Sensitive: A1 - Approval
bevacizumab-maly
Sensitive
:
A1
No biomarker
Glioblastoma
No biomarker
Glioblastoma
bevacizumab-adcd
Sensitive: A1 - Approval
bevacizumab-adcd
Sensitive
:
A1
bevacizumab-adcd
Sensitive: A1 - Approval
bevacizumab-adcd
Sensitive
:
A1
IDH1 mutation
Astrocytoma
IDH1 mutation
Astrocytoma
temozolomide
Sensitive: A2 - Guideline
temozolomide
Sensitive
:
A2
temozolomide
Sensitive: A2 - Guideline
temozolomide
Sensitive
:
A2
BRAF V600E
Glioblastoma
BRAF V600E
Glioblastoma
trametinib + dabrafenib
Sensitive: A2 - Guideline
trametinib + dabrafenib
Sensitive
:
A2
trametinib + dabrafenib
Sensitive: A2 - Guideline
trametinib + dabrafenib
Sensitive
:
A2
No biomarker
Glioblastoma
No biomarker
Glioblastoma
PCV
Sensitive: A2 - Guideline
PCV
Sensitive
:
A2
PCV
Sensitive: A2 - Guideline
PCV
Sensitive
:
A2
No biomarker
Anaplastic Astrocytoma
No biomarker
Anaplastic Astrocytoma
PCV
Sensitive: A2 - Guideline
PCV
Sensitive
:
A2
PCV
Sensitive: A2 - Guideline
PCV
Sensitive
:
A2
No biomarker
Glioma
No biomarker
Glioma
PCV
Sensitive: A2 - Guideline
PCV
Sensitive
:
A2
PCV
Sensitive: A2 - Guideline
PCV
Sensitive
:
A2
MGMT promoter methylation
Glioblastoma
MGMT promoter methylation
Glioblastoma
temozolomide
Sensitive: A2 - Guideline
temozolomide
Sensitive
:
A2
temozolomide
Sensitive: A2 - Guideline
temozolomide
Sensitive
:
A2
IDH2 mutation + Chr del(1p) + Chr del(19q)
Oligodendroglioma
IDH2 mutation + Chr del(1p) + Chr del(19q)
Oligodendroglioma
temozolomide
Sensitive: A2 - Guideline
temozolomide
Sensitive
:
A2
temozolomide
Sensitive: A2 - Guideline
temozolomide
Sensitive
:
A2
No biomarker
Glioma
No biomarker
Glioma
temozolomide
Sensitive: A2 - Guideline
temozolomide
Sensitive
:
A2
temozolomide
Sensitive: A2 - Guideline
temozolomide
Sensitive
:
A2
BRAF V600E
Ganglioglioma
BRAF V600E
Ganglioglioma
trametinib + dabrafenib
Sensitive: A2 - Guideline
trametinib + dabrafenib
Sensitive
:
A2
trametinib + dabrafenib
Sensitive: A2 - Guideline
trametinib + dabrafenib
Sensitive
:
A2
No biomarker
Glioma
No biomarker
Glioma
bevacizumab
Sensitive: A2 - Guideline
bevacizumab
Sensitive
:
A2
bevacizumab
Sensitive: A2 - Guideline
bevacizumab
Sensitive
:
A2
BRAF V600E
Ganglioglioma
BRAF V600E
Ganglioglioma
vemurafenib + cobimetinib
Sensitive: A2 - Guideline
vemurafenib + cobimetinib
Sensitive
:
A2
vemurafenib + cobimetinib
Sensitive: A2 - Guideline
vemurafenib + cobimetinib
Sensitive
:
A2
BRAF V600E
Ganglioglioma
BRAF V600E
Ganglioglioma
vemurafenib
Sensitive: A2 - Guideline
vemurafenib
Sensitive
:
A2
vemurafenib
Sensitive: A2 - Guideline
vemurafenib
Sensitive
:
A2
BRAF V600E
Astrocytoma
BRAF V600E
Astrocytoma
trametinib + dabrafenib
Sensitive: A2 - Guideline
trametinib + dabrafenib
Sensitive
:
A2
trametinib + dabrafenib
Sensitive: A2 - Guideline
trametinib + dabrafenib
Sensitive
:
A2
No biomarker
Astrocytoma
No biomarker
Astrocytoma
lomustine + procarbazine hydrochloride + vincristine liposomal
Sensitive: A2 - Guideline
lomustine + procarbazine hydrochloride + vincristine liposomal
Sensitive
:
A2
lomustine + procarbazine hydrochloride + vincristine liposomal
Sensitive: A2 - Guideline
lomustine + procarbazine hydrochloride + vincristine liposomal
Sensitive
:
A2
No biomarker
Glioblastoma
No biomarker
Glioblastoma
lomustine
Sensitive: A2 - Guideline
lomustine
Sensitive
:
A2
lomustine
Sensitive: A2 - Guideline
lomustine
Sensitive
:
A2
No biomarker
Glioblastoma
No biomarker
Glioblastoma
regorafenib
Sensitive: A2 - Guideline
regorafenib
Sensitive
:
A2
regorafenib
Sensitive: A2 - Guideline
regorafenib
Sensitive
:
A2
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login